[1] Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum, 1992,35:630-640. [2] Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum, 1992,35:630-640. [3] Jara LJ, Gomez-Sanchez C, Silveira LH, et al. Hyperprolactinemia in systemic lupus erythematosus: association with disease activity. Am J Med Sci, 1992,303:222-226. [4] Larrea F, Martinez-Castillo A, Cabrera V, et al.A bioactive 60-kilodalton prolactin spec ies is preferentially secreted in cultures of mitogen-stimulated and nonstimulated peripheral blood mononuclear cells from subjects with systemic lupus erythematosus. J Clin Endocrinol Metab, 1997,82:3664-3669. [5] Allen SH, Sharp GC, Wang G, et al.Prolactin levels and antinuclear antibody profiles in women tested for connective tissue disease. Lupus, 5:30-37. [6] Miranda JM, Prieto RE, Paniagua R, et al. Clinical significance of serum and urine prolactin levels in lupus glomerulonephritis. Lupus,1998,7:387-391. [7] 李锋,冯树芳,徐金华,等系统性红斑狼疮患者血清生长激素和泌乳素水平动态变化的研究.中华皮肤科杂志,2000,33:261-263 [8] Brennan P, Hajeer A, Ong KR,et al. Allelic markers close to prolactin are associated with HLA-DRB1 susceptibility alleles among women with rheumatoid arthritis and systemic lupus erythematosus.Arthritis Rheum, 1997,40:1383-1386. |